APA

Buter J., Sleijfer D. T., Willemse P. H., van der Graaf W. T., de Vries E. G., Schraffordt Koops H. & Mulder N. H. (19940922). Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma. : Anticancer research.

Chicago

Buter J, Sleijfer D T, Willemse P H, van der Graaf W T, de Vries E G, Schraffordt Koops H and Mulder N H. 19940922. Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma. : Anticancer research.

Harvard

Buter J., Sleijfer D. T., Willemse P. H., van der Graaf W. T., de Vries E. G., Schraffordt Koops H. and Mulder N. H. (19940922). Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma. : Anticancer research.

MLA

Buter J, Sleijfer D T, Willemse P H, van der Graaf W T, de Vries E G, Schraffordt Koops H and Mulder N H. Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma. : Anticancer research. 19940922.